1. Introduction {#sec1-molecules-22-01071}
===============

Cutaneous leishmaniasis (CL), the most common form of leishmaniasis, largely affects poor and developing countries in Africa, the Mediterranean Basin, the Middle East, central Asia (the Old World) and South America (the New World). The estimated number of new CL cases worldwide ranges from 0.7 million to 1.3 million annually \[[@B1-molecules-22-01071]\].

CL is caused by protozoan parasites of the *Leishmania* (*L.*) genus. Infected female phlebotomine sand flies inject these parasites from their proboscis to human when they take their blood meals. Skin lesions, the clinical signs of CL, develop within several weeks or months after exposure. These lesions are sometimes self-healing without treatment, or become chronic. In cases of ulcers healing, they leave permanent deep scars, which often cause a serious social prejudice. Conversely, if the disease becomes chronic, there is a high risk of severe bacterial infection. CL in the New World, mainly caused by *L. mexicana*, *L. amazonensis*, *L. venezuelensis*, *L. braziliensis*, *L. guyanensis*, *L. panamensis*, and *L. peruviana*, is usually more severe and lasts longer than that in the Old World, which is caused by *L. tropica*, *L. major*, *L. aethiopica*, *L. infantum* and *L. donovani*. Moreover, CL due to *L. mexicana*, *L. amazonensis* and *L. panamensis* can develop to diffuse forms. Lesions can spread from the skin to the mucosal surfaces of the nose or the mouth, leading to chronic stuffiness, bleeding, and inflamed mucosa or sores. In advanced cases, it can lead to the ulcerative destruction of the nose (such as perforation of the nasal septum), mouth, and pharynx \[[@B1-molecules-22-01071],[@B2-molecules-22-01071]\].

Drugs are the only therapeutic option for the treatment of CL as there is no vaccine at the moment. However, existing drugs, such as pentavalent antimonials and miltefosine, have serious drawbacks in terms of safety, efficacy, cost and difficulty in administration \[[@B3-molecules-22-01071],[@B4-molecules-22-01071]\]. Moreover, diffuse CL initially responding to the standard treatment relapses and becomes unresponsive to further treatments \[[@B2-molecules-22-01071]\]. Research on a safer, more effective, and shorter-course treatment for CL is therefore urgent. Nevertheless, the development of new medicines for treatment of this disease is challenging because of the variety of parasite species, pathology and immune responses \[[@B2-molecules-22-01071]\].

Essential oils (EOs), also known as volatile oils, are natural products formed by a mixture of volatile compounds produced by many plants. They are known to be biologically active, mainly possessing antibacterial, antifungal, and antioxidant properties. There are more and more studies on EOs biological activity because they are usually devoid of long-term genotoxic risks \[[@B5-molecules-22-01071]\]. Interestingly, topical application, the most frequent way to administer EOs, is recommended to be explored for the development of new anti-leishmanial drugs targeting CL because of their effectiveness and safety \[[@B2-molecules-22-01071]\]. Several EOs showed interesting potential to be used as new anti-parasitic drugs such as those extracted from *Chenopodium ambrosioides* L. (a synonym of *Dysphania ambrosioides* (L.) Mosyakin & Clemant) \[[@B6-molecules-22-01071],[@B7-molecules-22-01071]\] or *Bixa orellana* L. \[[@B8-molecules-22-01071]\]. However, EOs are complex mixtures of several compounds and their compositions vary according to many factors, such as plant's environment and growing conditions, methods of harvesting, extraction and storage. Moreover, the major component of an EO can also vary in different chemotypes of the same plant species. This chemical variability can influence their activities or adverse effects. Therefore, a clear knowledge of the EO composition is necessary \[[@B9-molecules-22-01071]\].

With the aim of discovering new natural products against *Leishmania mexicana mexicana* and developing active EOs or compounds for topical application, 37 Vietnamese plants were selected for anti-leishmanial investigation in our work. It is the first time that these Vietnamese EOs were tested on this *Leishmania* species. Moreover, this study also presents the results of chemical composition analyses of the most interesting samples.

2. Results {#sec2-molecules-22-01071}
==========

A primary screening was performed at concentrations of 50 and 25 nL/mL for the 37 EOs. The results showed that among them five EOs, extracted from *Amomum aromaticum*, *Cinnamomum cassia*, *Elsholtzia ciliata*, *Ocimum gratissimum*, and *Zingiber zerumbet*, displayed a promising effect against *Leishmania mexicana mexicana* (*Lmm*) promastigotes with less than 1% viable parasites at the lower concentration tested ([Table 1](#molecules-22-01071-t001){ref-type="table"}).

These selected EOs were further analyzed for dose-response activity to calculate IC~50~ value and for cytotoxicity on mammalian cells. The results are summarized in [Table 2](#molecules-22-01071-t002){ref-type="table"}. All selected EOs revealed high potential against promastigote form of *Lmm* with IC~50~ values lower than 10 nL/mL. However, four of them also showed toxicity on mammalian cells, as indicated by their SI \< 10. Our data demonstrated that the most active and selective EO was extracted from *Ocimum gratissimum* with an IC~50~ value on *Lmm* promastigotes of 4.85 ± 1.65 nL/mL and no toxicity towards mammalian cells at the highest tested concentration (50 nL/mL), as evidenced by more than 80% viable cells after 72 h of incubation.

To define their composition and further determine active compounds, the five selected EOs were analyzed by GC-MS and GC-FID ([Table 3](#molecules-22-01071-t003){ref-type="table"}). Identified compounds accounted for more than 90% for each EO. Eucalyptol (55.2%), *trans*-cinnamaldehyde (83.6%), citral (neral and geranial) (40.2%), eugenol (86.5%), and zerumbone (60.3%) were characterized as the main components of EOs extracted from *A. aromaticum*, *C. cassia*, *E. ciliata*, *O. gratissimum*, and *Z. zerumbet*, respectively.

It is important to point out that eugenol is the major compound (86.5%) of the EO extracted from *O. gratissimum*, which was shown to be the most selective active sample. In order to understand the activity of this EO, in vitro anti-leishmanial activity and cytotoxicity of eugenol were studied. Interestingly, the IC~50~ value against *Lmm* promastigotes of eugenol was 2.57 ± 0.57 nL/mL (=2.72 µg/mL, 15.67 µM) and more than 80% of mammalian cells were living after 72 h when incubated at the maximal concentration used (50 nL/mL).

3. Discussion {#sec3-molecules-22-01071}
=============

This study analyzed the in vitro activity of 37 EOs extracted from Vietnamese plants against *Leishmania mexicana mexicana*. According to the classification of anti-parasitic activity from literature, extracts that showed effect against parasites with IC~50~ value ≤2 µg/mL (or 2 µM for pure compounds) are cited as having good activity, those with IC~50~ between 2 and 20 µg/mL (or micro molar for pure compounds) are considered as having a moderate activity, while those with higher IC~50~ value were considered as less interesting \[[@B11-molecules-22-01071]\]. In this study, the primary screening was performed against *Lmm* promastigotes at concentrations of 25 and 50 nL/mL in order to quickly identify interesting EOs (1 nL is a little less than 1 µg depending on the density of the EO) \[[@B11-molecules-22-01071]\]. Our data showed that percentages of viable parasites incubated with the lower concentration of five EOs, extracted from *A. aromaticum*, *C. cassia*, *E. ciliata*, *O. gratissimum*, and *Z. zerumbet*, were lower than 1%, meaning that these EOs revealed a potential activity. Indeed, the IC~50~ values of these selected EOs were lower than 10 nL/mL in the second analysis.

To have a general look at anti-leishmanial activity and cytotoxicity of the five more active EOs and to understand their observed effects, we compiled literature data of EOs extracted from similar plant species and also of their major components in [Table 4](#molecules-22-01071-t004){ref-type="table"}.

As shown in this table, among the five selected samples, EOs obtained from *A. aromaticum*, *C. cassia*, and *E. ciliata* were analyzed here for the first time for their leishmanicidal effect. In our experiment, they showed IC~50~ values of 9.25 ± 0.64, 2.29 ± 0.08, and 8.49 ± 0.32 nL/mL, respectively against *Lmm* promastigotes. Unfortunately, this activity was not very selective on *Leishmania* as SI values compared to non-cancer mammalian cells (WI38) and cancer cells (J774) were approximately 5 and 2, respectively.

Two EOs extracted from *O. gratissimum* and *Z. zerumbet* were already investigated for anti-leishmanial activity \[[@B13-molecules-22-01071],[@B14-molecules-22-01071],[@B15-molecules-22-01071],[@B16-molecules-22-01071]\] however on other *L.* species. The EO extracted from fresh leaves of *O. gratissimum* collected in Brazil did not reveal interesting effects against both *L. amazonensis* and *L. chagasi*. On the contrary, in our study, the EO extracted from *O. gratissimum* collected in Vietnam demonstrated notable activity against *Lmm* promastigotes, with an IC~50~ value of 4.85 ± 1.65 nL/mL. These results indicated a specific activity of this EO related to parasite species (*Leishmania mexicana mexicana*) and/or collection place and composition. Another important feature of this EO is its absence of cytotoxicity as the percentages of viable WI38 and J774 cells at the maximal tested concentration (50 nL/mL) were higher than 80%. We therefore selected the EO extracted from *O. gratissimum* as the most active and selective sample. Regarding the EO extracted from fresh rhizomes of *Z. zerumbet*, its activity against *L. donovani* was in the same range than what we found against *Lmm* promastigotes (IC~50~ = 3.34 ± 0.34 nL/mL). Unfortunately, we also observed cytotoxicity of this EO on WI38 and J774 cells as shown by SI values of 1.10 and 0.72, respectively.

Eucalyptol, the major compound of the EO extracted from *A. aromaticum* (55.2%), was not active against the different tested *L.* species \[[@B17-molecules-22-01071],[@B18-molecules-22-01071]\]. Other components present in our *A. aromaticum* EO, such as citral (neral and geranial, 9.6%), 2-(*E*)-decenal (5.3%), α-terpineol (2.8%), β-pinene (2.6%) and α-pinene (2.1%) may be therefore responsible, in part, of the observed activity. Among these compounds, 2-(*E*)-decenal and α-pinene have already shown leishmanicidal effects. IC~50~ values of 2-(*E*)-decenal against *L. donovani* promastigotes and axenic amastigotes were 7.85 ± 0.28 and 2.47 ± 0.25 µg/mL respectively \[[@B29-molecules-22-01071]\], and IC~50~ value of α-pinene against *L. amazonensis* promastigotes, *L. amazonensis* axenic amastigotes and *L. infantum* promastigotes were 19.7, 16.1 and 45.94 µg/mL respectively \[[@B17-molecules-22-01071],[@B30-molecules-22-01071]\].

Citral was characterized as the main component of the EO extracted from *E. ciliata* (40.2%). It showed a moderate activity against *L. donovani*, *L. amazonensis* and a weak effect against *L. infantum*, *L. tropica* and *L. major* \[[@B20-molecules-22-01071],[@B21-molecules-22-01071],[@B22-molecules-22-01071]\]*.* However, it is important to point out that this compound is not selective on *Leishmania* as shown by the toxicity on kidney epithelial and J774 cells \[[@B20-molecules-22-01071],[@B21-molecules-22-01071]\]. Our results indicated activity on parasites and mammalian cells of the EO extracted from *E. ciliata* in the same range than citral with IC~50~ value of 8.49 ± 0.32 nL/mL and SI of 5.58 (compared to WI38) and 1.56 (compared to J774). Nevertheless, citral being present at only 40.2% in the *E. ciliata* EO, other compounds should also have anti-leishmanial activity as β-(*E*)-ocimene (14.0%), linalool (8.3%), 1-octen-3-ol (7.1%) and β*-*(*E*)-farnesene (6.2%). Dutra et al. have already examined leishmanicidal effect of linalool on *L. infantum chagasi*. However when axenic amastigotes were treated with linalool, IC~50~ was 550 µg/mL \[[@B24-molecules-22-01071]\].

EO extracted from *C. cassia* contained 83.6% of *trans*-cinnamaldehyde. The anti-leishmanial activity of this compound is unknown but its toxicity on two human cell lines was determined \[[@B19-molecules-22-01071]\]. In our sample, the high percentage of cinnamaldehyde may explain the toxicity of this EO on both mammalian cell lines, WI38 and J774, with IC~50~ of 14.19 ± 0.54 and 6.26 ± 0.80 nL/mL respectively. Given the known cytotoxicity of this compound and its high concentration in the *C. cassia* EO, we did not find interesting to further analyze its anti-parasitic activity.

As mentioned previously, eugenol was characterized as the major compound (86.5%) of the most interesting EO extracted from our Vietnamese sample of *O. gratissimum*. Literature data indicated a moderate effect on *L. amazonensis* and a less interesting activity against *L. infantum chagasi* of eugenol \[[@B23-molecules-22-01071],[@B24-molecules-22-01071],[@B25-molecules-22-01071]\]. On L. *donovani*, along with a moderate in vitro activity, in vivo effect of eugenol (emulsified) was determined. The intra-peritoneal administration of an eugenol emulsion at the dose of 75 mg/kg b.w. for 10 consecutive days decreased by 87.01 ± 5.85 and 86.68 ± 5.42% parasitic load in spleen and liver, respectively, in 8-weeks infected BALB/c mice. Moreover, a significant reduction in spleen size, and spleen and liver weights were also found at this dose \[[@B26-molecules-22-01071]\]. Our results further support the anti-leishmanial activity of this compound with IC~50~ value of 2.57 ± 0.57 nL/mL (=2.72 µg/mL or 15.67 µM) against *Lmm* promastigotes. Interestingly, eugenol was not toxic on both non-cancer and cancer mammalian cells in our models at the highest analyzed concentration (50 nL/mL). From these results, and its high percentage in the *O. gratissimum* EO, it can be concluded that activity of eugenol can explain the anti-leishmanial activity of this EO.

Zerumbone, accounting for 60.3% of the EO extracted from fresh rhizomes of *Z. zerumbet*, was reported to be active against *L. donovani*, however it revealed toxicity on human leukemia cells HL-60 \[[@B27-molecules-22-01071],[@B28-molecules-22-01071]\]. These data can explain the anti-leishmanial activity but also cytotoxicity of the *Z. zerumbet* EO found in our study.

Mechanisms of anti-leishmanial activity of these EOs and their major compounds are not well known. Usually, effects were analyzed on the morphology of treated parasites or as a consequence of immunostimulatory activities.

Most of the studies used transmission electron microscopy (TEM) and scanning electron microscopy (SEM) to analyze the morphology of EOs treated parasites. The EO extracted from *O. gratissimum* caused considerable mitochondrial swelling in *L. amazonensis* promastigotes at 135 µg/mL and amastigotes at 100 µg/mL \[[@B13-molecules-22-01071]\], swelling of cell body, flagellar pocket and mitochondria in *L. chagasi* promastigotes at 50 µg/mL \[[@B15-molecules-22-01071]\]. Ultrastructure alterations were also observed in *L. amazonenesis* and *L. infantum* promastigotes treated with citral at concentrations of 8.0 and 42 µg/mL respectively \[[@B21-molecules-22-01071],[@B22-molecules-22-01071]\]. Mukherjee et al. detected morphological alterations by SEM in *L. donovani* promastigotes treated with 9.36 µM of zerumbone associated with induced ROS-mediated apoptosis \[[@B27-molecules-22-01071]\].

Using other experiments, citral at the concentration of 42 µg/mL was shown to trigger programmed cell death of *L. infantum* promastigotes, as indicated by the externalization of phosphatidylserine, loss of mitochondrial membrane potential and cell-cycle arrest at the G(0)/G(1) phase \[[@B22-molecules-22-01071]\].

Regarding immunostimulatory activity, an increase of nitric oxide produced by infected macrophages has been suggested to be responsible for the activity of the *O. gratissimum* EO against *L. amazonensis* at 100 and 150 µg/mL \[[@B13-molecules-22-01071]\]. Islamuddin et al. explored the synergic effect between eugenol emulsion and the immune system. In BALB/mice infected by *L. donovani*, treatment with 75 mg/kg b.w. of eugenol emulsion enhanced IFN-γ and IL-2 serum levels, as well as increased CD4+ and CD8+ T cell population and expanded IFN-γ producing CD4+ and CD8+ splenic T lymphocytes \[[@B26-molecules-22-01071]\].

Concerning the mechanism of eugenol activity, although no data are available on *Lmm* promastigotes, some experiments were carried out on bacteria and fungi. Eugenol at concentrations of 5.3 and 10.6 mg/mL was reported to significantly damage both the cell wall and membrane of the treated Gram-negative and Gram-positive bacteria \[[@B31-molecules-22-01071]\]. Khan et al. observed damaging effects of eugenol at 200 µg/mL on cell wall, cell membrane, cytoplasmic contents and other membranous structures of treated *Candida albicans* \[[@B32-molecules-22-01071]\]. Indeed, because of the lipophilicity of eugenol, it could easily diffuse between the fatty acyl chains of lipid bilayers modifying the fluidity, integrity and permeability of cell membranes \[[@B31-molecules-22-01071]\]. We now intend to analyze possible effects of this compound on leishmanial membranes.

4. Materials and Methods {#sec4-molecules-22-01071}
========================

4.1. Plants Collection {#sec4dot1-molecules-22-01071}
----------------------

Thirty-seven plants were collected from different areas of Vietnam in November 2014 and from May to August 2015. They were identified by matching with literature and herbarium specimen at the Botanical Department, Hanoi University of Pharmacy, Vietnam. The information of sample name, genus, species, family, and collector name is given in the [supplementary material](#app1-molecules-22-01071){ref-type="app"}.

4.2. Essential Oils Extraction {#sec4dot2-molecules-22-01071}
------------------------------

Fresh samples were extracted by hydro-distillation using a modified Clavenger apparatus for two hours. Each essential oil obtained from hydro-distillation was dried using sodium sulfate, filtered and kept refrigerated prior to analysis. Stock solutions at the concentration of 20 µL/mL were prepared in DMSO and diluted further in culture medium to achieve a maximum final DMSO concentration of 0.25%.

4.3. Culture Maintenance {#sec4dot3-molecules-22-01071}
------------------------

Promastigote form of *Leishmania mexicana mexicana* (*Lmm*, MHOM/BZ/84/BEL46) was grown in SDM 79 medium (Life technologies, Ghent, Belgium) supplemented with 15% heat-inactivated fetal bovine serum and 0.2% hemin. The culture was maintained at 28 °C in 5% CO~2~ incubator. The human non-cancer fibroblast cell line WI38 (ATCC Number CCL-75 from LGC Standards, Middlesex, UK) and macrophage-like murine cell line J774 (ECACC Number 91051511 from Public Health England, Salisbury, UK) were grown in DMEM and RPMI medium (Gibco from Thermo Fisher Scientific, Merelbeke, Belgium or Sigma-Aldrich, Bornem, Belgium), respectively, supplemented with 10% fetal bovine serum and penicillin-streptomycin (100 UI/mL). The culture was maintained at 37 °C in 5% CO~2~ incubator.

4.4. Anti-leishmanial Assay {#sec4dot4-molecules-22-01071}
---------------------------

The *Lmm* promastigote density was counted on a haemocytometer and adjusted to 10^5^ parasites/mL. The assays were performed in 96-well plates. For primary screening (repeated two times at concentrations of 50 and 25 nL/mL in triplicate) essential oils were diluted in culture medium from the stock solutions (20 µL/mL). Each well was filled with 50 μL of the diluted essential oil and 50 μL of the *Lmm* promastigote culture (total volume 100 μL). After 72 h of incubation, 10 µL Alamar blue (Thermo Fisher Scientific, diluted with PBS at the ratio 1:1) was added to each well and the plates were further incubated for 4 h. Fluorescence was measured on a spectrophotometer (SpectraMax-Molecular Devices, Berkshire, UK) at 530 nm excitation and 590 nm emission wavelengths. Pentamidine was tested as standard drug. The essential oils that inhibited more than 50% the growth of *Lmm* promastigotes at the concentration of 25 nL/mL in the primary screening were submitted to a second analysis for accurate IC~50~ determination. Selected essential oils were screened at least three times at concentrations ranging from 50 to 0.02 nL/mL in duplicate. IC~50~ values were calculated from dose response growth inhibition curves by Microsoft excel files.

4.5. Cytotoxicity Assay {#sec4dot5-molecules-22-01071}
-----------------------

The essential oils which were analyzed for IC~50~ value on anti-leishmanial assay were also analyzed for cytotoxicity against non-cancer (WI38) and cancer (J774) mammalian cells. The culture of cells was diluted with medium to the adequate density of 5 × 10^3^ cells/mL and then 180 μL was added into each well of 96-well plates. After 24 h of incubation, 20 μL of essential oils diluted in culture medium was added to each well (to obtain concentrations ranging from 50−0.02 nL/mL) for further 72 h of incubation. After removing the medium, 100 μL of MTT was added to each well and the plates were further incubated for 45 minutes. 100 μL of DMSO was used to dissolve formed formazan crystals after MTT removing. Absorbance was measured on a spectrophotometer (SpectraMax-Molecular Devices, Berkshire, UK) at 570 nm with a reference wavelength at 620 nm. All experiments were made at least two times in triplicate. The computation of the IC~50~ values was performed with GraphPad Prism 5.0 (GraphPad Software Inc., San Diego, CA, USA). The selectivity index (SI) values were calculated using the formula below:

4.6. Essential Oil Analysis {#sec4dot6-molecules-22-01071}
---------------------------

The GC-MS analyses were carried out on a TRACE GC 2000 series (Thermo-Quest, Rodano, Italy), with a DB-WAX capillary column (30 m × 0.25 mm × 0.25 µm) using the following operating conditions: injection volume: 1 µL (TBME solution); injection mode: splitless; injector temperature: 230 °C; oven temperature: increased from 45 °C (held on 5 min) to 250 °C (held on 5 min) at 3 °C/min; helium was used as a carrier gas at a constant flow of 1.3 mL/min; detector temperatures: 260 °C; ion source: 70 eV. The oil components were identified using linear retention indices in relation to a series of fatty acid methyl esters (C~5~--C~27~), pure compounds and NIST mass spectral library (matching coefficient \> 700). GC-FID was done using the same column and conditions on a FOCUS GC (Thermo Finnigan, Milan, Italy) with modifications of injection mode (split at ratio 1:50) and detector temperature (250 °C). Percentage of compounds was calculated by the normalization procedure.

5. Conclusions {#sec5-molecules-22-01071}
==============

The present study analyzes for the first time the anti-leishmanial activity of 37 essential oils extracted from Vietnamese plants. Those extracted from *A. aromaticum*, *C. cassia* and *E. ciliata* are shown here for the first time to be effective on a *Leishmania* species, while the effects of *O. gratissimum* and *Z. zerumbet* EOs are reported for the first time on *L. mexicana* species. More than 90% of their contents was characterized. Eugenol was identified as the major compound of the *O. gratissimum* EO, the most active and selective one. This compound, showing a moderate anti-leishmanial activity and low cytotoxicity in the tested models, can explain this EO activity. However, further results are necessary before developing it in the treatment of cutaneous leishmaniasis such as in vivo assessment in *Lmm* infected animals and determination of its mode of action.

The authors gratefully acknowledge Vietnamese Ministry of Education and Training and Belgian National Fund for Scientific Research (FNRS) (PDR T.0190.13) for financial support. We wish to thank Marie-France Hérent and Marie-Christine Fayt for skillful technical assistance in GC and all the members of the Pharmacognosy group from LDRI, UCL, Belgium, for helpful scientific advices and support.

**Sample Availability:** Samples of essential oils are available from the authors.

Supplementary materials are available online.

###### 

Click here for additional data file.

Thanh Binh Le directly collected plants, performed chemical, anti-leishmanial activity and cytotoxicity experiments, analyzed the data; Claire Beaufay participated in analyzes of the data and discussions during the work; Duc Trong Nghiem was responsible for the plants identification; Marie-Paule Mingeot-Leclercq participated in discussions during the work; Joëlle Quetin-Leclercq was responsible for the conception of this work. They also wrote this article.

The authors declare no conflict of interest.

molecules-22-01071-t001_Table 1

###### 

Viability of *Lmm* promastigotes in the presence of 25 nL/mL EO.

  Plant Species                                      EO Obtained From   Viability of *Lmm* promastigotes (%) (Average ± Standard Deviation)
  -------------------------------------------------- ------------------ ---------------------------------------------------------------------
  *Ageratum conyzoides* (L.) L.                      leaves             89.84 ± 1.58
  *Alpinia galanga* (L.) Willd.                      rhizomes           93.02 ± 4.90
  ***Amomum aromaticum* Roxb.**                      **fruits**         **0.27 ± 0.05**
  *Amomum schmidtii* (K. Schum.) Gagnep.             rhizomes           96.82 ± 1.13
  *Anethum graveolens* L.                            fruits             96.53 ± 1.26
  *Artemisia annua* L.                               leaves             92.32 ± 1.55
  *Blumea lanceolaria* (Roxb.) Druce                 leaves             93.59 ± 1.24
  ***Cinnamomum cassia* (L.) J. Presl**              **stem barks**     **0.48 ± 0.01**
  *Clausena indica* (Dalzell) Oliv.                  leaves             95.07 ± 7.40
  *Coriandrum sativum* L.                            fruits             94.47 ± 2.38
  *Curcuma longa* L.                                 rhizomes           92.90 ± 1.61
  *Curcuma zedoaria* (Christm.) Roscoe               rhizomes           99.53 ± 0.23
  *Dysphania ambrosioides* (L.) Mosyakin & Clemant   leaves, fruits     92.69 ± 1.93
  *Elsholtzia blanda* (Benth.) Benth.                leaves             94.70 ± 6.12
  ***Elsholtzia ciliata* (Thunb.) Hyl.**             **leaves**         **0.38 ± 0.00**
  *Elsholtzia communis* (Collett & Hemsl.) Diels     leaves             97.24 ± 2.19
  *Elsholtzia penduliflora* W. W. Sm.                leaves             97.88 ± 0.37
  *Eucalyptus camaldulensis* Dehnh.                  leaves             101.13 ± 0.54
  *Hedychium coronarium* J.Koenig                    rhizomes           91.79 ± 4.60
  *Hyptis suaveolens* (L.) Poit.                     leaves             67.32 ± 1.97
  *Illicium verum* Hook. f.                          fruits             93.35 ± 5.29
  *Kaempferia galanga* L.                            rhizomes           100.00 ± 7.47
  *Litsea cubeba* (Lour.) Pers.                      fruits             96.00 ± 5.18
  *Litsea cubeba* (Lour.) Pers.                      leaves             94.67 ± 2.99
  *Melaleuca alternifolia* (Maiden & Betch) Cheel    leaves             87.61 ± 4.93
  *Melaleuca cajuputi* Powell                        leaves             92.53 ± 3.17
  ***Ocimum gratissimum* L.**                        **leaves**         **0.13 ± 0.01**
  *Ocimum tenuiflorum* L.                            leaves             89.08 ± 5.23
  *Piper sarmentosum* Roxb.                          leaves             81.43 ± 14.12
  *Platycladus orientalis* (L.) Franco               leaves             92.41 ± 16.49
  *Plectranthus amboinicus* (Lour.) Spreng.          leaves             82.06 ± 1.50
  *Pluchea indica* (L.) Less.                        leaves             88.07 ± 4.37
  *Pogostemon cablin* (Blanco) Benth.                leaves             93.64 ± 1.51
  *Vitex trifolia* L.                                leaves             88.70 ± 3.34
  *Zingiber montanum* (J.Koenig) Link ex A.Dietr.    rhizomes           88.36 ± 1.59
  *Zingiber officinale* Roscoe                       rhizomes           94.29 ± 3.83
  ***Zingiber zerumbet* (L.) Roscoe ex Sm.**         **rhizomes**       **0.19 ± 0.05**

molecules-22-01071-t002_Table 2

###### 

In vitro anti-leishmanial activity, cytotoxicity and selectivity indices of the five selected EOs.

  Plant Species          Anti-Leishmanial Activity (IC~50~ nL/mL) Average ± Standard Deviation   Cytotoxicity (IC~50~ nL/mL) Average ± Standard Deviation                             
  ---------------------- ----------------------------------------------------------------------- ---------------------------------------------------------- -------- ---------------- --------
  *Amomum aromaticum*    9.25 ± 0.64                                                             47.31 ± 0.30                                               5.11     22.68 ± 3.22     2.45
  *Cinnamomum cassia*    2.92 ± 0.08                                                             14.19 ± 0.54                                               4.85     6.26 ± 0.80      2.14
  *Elsholtzia ciliata*   8.49 ± 0.32                                                             47.38 ± 1.64                                               5.58     13.21 ± 1.48     1.56
  *Ocimum gratissimum*   4.85 ± 1.65                                                             \>50                                                       \>10.3   \>50             \>10.3
  *Zingiber zerumbet*    3.34 ± 0.34                                                             3.68 ± 0.34                                                1.10     2.41 ± 0.04      0.72
  Pentamidine            0.04 ± 0.006 \*                                                                                                                                              
  Camptothecin                                                                                   0.13 ± 0.02 \*                                                      0.01 ± 0.01 \*   

\* concentration in µg/mL.

molecules-22-01071-t003_Table 3

###### 

Chemical composition of the five selected EOs.

  No.      Compounds                                  RI            Relative Percentages (%)   Identification                                    
  -------- ------------------------------------------ ------------- -------------------------- ---------------- ---------- ---------- ---------- ------------------------------------------
  1        α-Pinene                                   535           2.1                        \-               \-         \-         2.3        MS, \[[@B10-molecules-22-01071]\], Co-GC
  2        Camphene                                   573−576       t                          \-               \-         \-         8.0        MS, \[[@B10-molecules-22-01071]\]
  3        β-Pinene                                   619−621       2.6                        \-               0.1        \-         0.2        MS, \[[@B10-molecules-22-01071]\], Co-GC
  4        Sabinene                                   634−635       t                          \-               t          0.2        \-         MS, \[[@B10-molecules-22-01071]\]
  5        3-Carene                                   664−665       0.1                        \-               \-         \-         1.1        MS
  6        α-Phellandrene                             682           \-                         \-               \-         \-         0.1        MS, Co-GC
  7        Myrcene                                    684           \-                         \-               0.2        0.2        0.4        MS, \[[@B10-molecules-22-01071]\]
  8        α-Terpinene                                697           \-                         \-               \-         t          \-         MS, \[[@B10-molecules-22-01071]\], Co-GC
  9        Limonene                                   719−720       0.8                        \-               4.1        \-         1.0        MS, \[[@B10-molecules-22-01071]\], Co-GC
  **10**   **Eucalyptol**                             **730-740**   **55.2**                   **-**            **-**      **-**      1.6        MS, \[[@B10-molecules-22-01071]\], Co-GC
  11       (*Z*)-β-Ocimene                            758−760       \-                         \-               0.7        5.4        \-         MS
  12       γ-Terpinene                                765−766       \-                         \-               t          0.1        t          MS, \[[@B10-molecules-22-01071]\], Co-GC
  13       (*E*)-β-Ocimene                            773−778       \-                         \-               14.0       0.2        \-         MS
  14       *p*-Cymene                                 787−792       0.6                        t                t          t          0.2        MS, \[[@B10-molecules-22-01071]\], Co-GC
  15       Terpinolene                                800−801       \-                         \-               t          t          0.1        MS, \[[@B10-molecules-22-01071]\], Co-GC
  16       Octanal                                    812           0.2                        \-               \-         \-         \-         MS
  17       (*E*)-3-Hexen-1-ol acetate                 837           \-                         \-               t          \-         \-         MS
  18       5-Hepten-2-one, 6-methyl-                  855−858       0.2                        \-               1.1        \-         \-         MS, Co-GC
  19       α-Pinene oxide                             875           \-                         \-               0.1        \-         \-         MS
  20       *allo*-Ocimene                             887           \-                         \-               \-         0.1        \-         MS, Co-GC
  21       1-Octen-1-yl acetate                       897           \-                         \-               1.0        \-         \-         MS
  22       (*Z*)-3-Hexen-1-ol                         902−904       \-                         \-               0.5        t          \-         MS, Co-GC
  23       Fenchone                                   907           \-                         \-               \-         \-         0.1        MS, Co-GC
  24       3-Octanol                                  915           \-                         \-               0.3        \-         \-         MS, \[[@B10-molecules-22-01071]\]
  25       (*E*)-2-Octenal                            945           0.6                        \-               \-         \-         \-         MS
  26       *cis*-Linalool oxide (furanoid)            961           t                          \-               \-         \-         \-         MS, Co-GC
  27       1-Octen-3-ol                               971           \-                         \-               7.1        \-         \-         MS, \[[@B10-molecules-22-01071]\]
  28       *cis*-Sabinene hydrate                     980           \-                         \-               \-         0.3        \-         MS
  29       Cyclosativene                              987           \-                         0.1              \-         \-         \-         MS
  30       *trans-*Linalool oxide (furanoid)          988           t                          \-               \-         \-         \-         MS, Co-GC
  31       Citronellal                                990           \-                         \-               t          \-         \-         MS, \[[@B10-molecules-22-01071]\], Co-GC
  32       α-Copaene                                  998−1003      \-                         4.2              \-         0.2        \-         MS
  33       Camphor                                    1020−1021     \-                         \-               0.4        \-         2.1        MS, \[[@B10-molecules-22-01071]\], Co-GC
  34       β-Bourbonene                               1023          \-                         \-               \-         0.2        \-         MS
  35       Benzaldehyde                               1027          \-                         1.0              t          \-         \-         MS
  36       β-Cubebene                                 1044          \-                         \-               \-         0.1        \-         MS
  37       Linalool                                   1060−1065     0.7                        \-               8.3        0.1        0.3        MS, \[[@B10-molecules-22-01071]\], Co-GC
  38       Terpinen-1-ol                              1077          0.1                        \-               \-         \-         \-         MS
  39       Bornyl acetate                             1086          \-                         \-               \-         \-         0.1        MS, Co-GC
  40       *trans-*α-Bergamotene                      1091−1092     \-                         t                t          \-         \-         MS, \[[@B10-molecules-22-01071]\]
  41       β-Elemene                                  1093−1094     \-                         0.2              \-         0.1        \-         MS
  42       β-Caryophyllene                            1098−1101     \-                         0.1              3.0        1.3        0.7        MS, \[[@B10-molecules-22-01071]\], Co-GC
  43       Terpinen-4-ol                              1108−1113     0.9                        t                t          0.2        0.2        MS, \[[@B10-molecules-22-01071]\], Co-GC
  44       Acetophenone                               1149          \-                         \-               0.7        \-         \-         MS
  45       (*E*)-2- Decenal                           1153          5.3                        \-               \-         \-         \-         MS
  46       α-Humulene                                 1166−1173     \-                         t                t          t          9.2        MS, \[[@B10-molecules-22-01071]\], Co-GC
  47       (*E*)-β-Farnesene                          1178          \-                         \-               6.2        \-         \-         MS
  48       γ-Muurolene                                1187−1188     \-                         0.5              \-         t          \-         MS
  **49**   **Neral**                                  1187−1188     3.2                        \-               **16.8**   \-         \-         MS, Co-GC
  50       Methyl geranate                            1197          \-                         \-               0.2        \-         \-         MS
  51       α-Terpineol                                1201−1207     2.8                        \-               0.4        \-         0.2        MS, \[[@B10-molecules-22-01071]\], Co-GC
  52       Borneol                                    1205          \-                         \-               \-         \-         0.2        MS, \[[@B10-molecules-22-01071]\], Co-GC
  53       Germacrene D                               1207          \-                         \-               \-         3.4        \-         MS, \[[@B10-molecules-22-01071]\]
  54       Geranyl formate                            1212          0.6                        \-               \-         \-         \-         MS
  55       β-Selinene                                 1214          \-                         0.1              \-         \-         \-         MS
  56       Neryl acetate                              1218          \-                         \-               t          \-         \-         MS, \[[@B10-molecules-22-01071]\], Co-GC
  57       α-Muurolene                                1224          \-                         0.8              \-         \-         \-         MS
  **58**   **Geranial**                               1238          6.4                        \-               **23.4**   \-         \-         MS
  59       β-Cadinene                                 1253−1254     \-                         \-               \-         0.2        0.1        MS
  60       δ-Cadinene                                 1257          \-                         2.0              \-         \-         \-         MS
  61       Geranyl acetate                            1259−1263     0.9                        \-               0.7        \-         \-         MS, \[[@B10-molecules-22-01071]\], Co-GC
  62       Citronellol                                1272          \-                         \-               0.5        \-         \-         MS, \[[@B10-molecules-22-01071]\], Co-GC
  63       Benzenepropanal                            1273          \-                         1.7              \-         \-         \-         MS
  64       *cis-*Cadina-1,4-diene                     1278          \-                         0.5              \-         \-         \-         MS
  65       Isogeraniol                                1289          \-                         \-               0.2        \-         \-         MS
  66       Nerol                                      1304          \-                         \-               3.5        \-         \-         MS, \[[@B10-molecules-22-01071]\], Co-GC
  67       *cis*-Isogeraniol                          1311          \-                         \-               0.4        \-         \-         MS
  68       (*E*)-2,6-dimethyl-3,5,7-octatriene-2-ol   1323−1324     \-                         \-               t          0.1        \-         MS
  69       *cis*-Calamenene                           1325          \-                         0.5              \-         \-         \-         MS
  70       Geraniol                                   1350−1354     2.4                        \-               3.1        \-         \-         MS, \[[@B10-molecules-22-01071]\], Co-GC
  71       (*E*)-2-Dodecenal                          1359          1.5                        \-               \-         \-         \-         MS
  72       *cis*-Cinnamaldehyde                       1382          \-                         2.4              \-         \-         \-         MS
  73       Indane-4-carboxalde-hyde                   1466          1.7                        \-               \-         \-         \-         MS
  74       Caryophyllene oxide                        1466−1501     \-                         \-               0.6        0.2        3.6        MS, \[[@B10-molecules-22-01071]\], Co-GC
  75       Humulene epoxide II                        1522          \-                         \-               \-         \-         2.2        MS
  **76**   ***trans-*Cinnamaldehyde**                 1534          \-                         **83.6**         \-         \-         \-         MS, Co-GC
  77       (*E*)-Nerolidol                            1533−1538     1.2                        \-               0.5        \-         \-         MS, \[[@B10-molecules-22-01071]\], Co-GC
  78       Cubenol                                    1552          \-                         0.2              \-         \-         \-         MS
  79       Elemol                                     1571          0.2                        \-               \-         \-         \-         MS
  80       Cinnamyl acetate                           1633          \-                         0.9              \-         \-         \-         MS
  **81**   **Eugenol**                                1657          \-                         \-               \-         **86.5**   \-         MS, Co-GC
  82       α-Muurolol                                 1669          \-                         0.1              \-         \-         \-         MS
  83       β-Eudesmol                                 1706          \-                         \-               \-         \-         0.2        MS
  84       α-Cadinol                                  1710          \-                         \-               \-         0.1        \-         MS
  85       Cinnamyl alcohol                           1761          \-                         0.2              \-         \-         \-         MS, Co-GC
  **86**   **Zerumbone**                              1831          \-                         \-               \-         \-         60.3       MS
  87       *o*-Methoxy-cinnamaldehyde                 1902          \-                         0.3              \-         \-         \-         MS
  88       *trans*-Phytol                             2085          \-                         \-               0.16       \-         \-         MS, Co-GC
           **Total identified**                                     **90.3**                   **99.4**         **98.3**   **99.2**   **94.5**   

t: trace (peak area less than 0.05%); RI: the retention index was calculated using a homologous series of fatty acid methyl esters C~5~--C~27~; MS: mass spectra (matching coefficient \>700 compared with NIST database); Co-GC: co-injection with pure compound.

molecules-22-01071-t004_Table 4

###### 

Profile of in vitro anti-leishmanial activity and cytotoxicity of the five more active EOs and their major compounds.

  Plants/Compounds                             Anti-Leishmanial Activity   Cytotoxicity                    Refs.                                                                                       
  -------------------------------------------- --------------------------- ------------------------------- --------------------------------- --------------------------------------------------------- ---------------------------------------------------------
  *A. aromaticum*                              ND                                                          ND                                                                                          
  *C. cassia*                                  ND                                                          ND                                                                                          
  *E. ciliata*                                 ND                                                          PC12 rat pheochromocytoma cells   \>50                                                      \[[@B12-molecules-22-01071]\]
  *O. gratissimum*                             *L. amazonensis*-proma.     135                             CHO                               125.00 ± 1.68                                             \[[@B13-molecules-22-01071],[@B14-molecules-22-01071]\]
  *L. amazonensis*-ama.                        100                         WI38                            165.51 ± 6.81                     \[[@B13-molecules-22-01071],[@B14-molecules-22-01071]\]   
  *L. chagasi*-proma.                          80                                                                                            \[[@B15-molecules-22-01071]\]                             
  *Z. zerumbet*                                *L. donovani*-proma.        4.62                            ND                                                                                          \[[@B16-molecules-22-01071]\]
  Eucalyptol                                   *L. infantum*-proma.        \>100                           Vero cell                         63.49                                                     \[[@B17-molecules-22-01071]\]
  *L. infantum*-ama.                           \>100                                                                                         \[[@B17-molecules-22-01071]\]                             
  *L. infantum*-proma.                         \>400                                                                                         \[[@B18-molecules-22-01071]\]                             
  *L. tropica*-proma.                          \>400                                                                                         \[[@B18-molecules-22-01071]\]                             
  *L. major*-proma.                            \>400                                                                                         \[[@B18-molecules-22-01071]\]                             
  Cinnamal-dehyde                              ND                                                          human embryonic stem cells        4.88                                                      \[[@B19-molecules-22-01071]\]
  human pulmonary fibroblasts                  5.28                        \[[@B19-molecules-22-01071]\]                                                                                               
  Citral                                       *L. donovani*-proma.        19                              kidney epithelial cell            22.4                                                      \[[@B20-molecules-22-01071]\]
  *L. amazonensis*-proma.                      8.0 ± 0.06                  J774                            50.0 ± 0.10                       \[[@B21-molecules-22-01071]\]                             
  *L. amazonensis*-ama.                        25 ± 0.29                                                                                     \[[@B21-molecules-22-01071]\]                             
  *L. infantum*-proma.                         42                                                                                            \[[@B22-molecules-22-01071]\]                             
  *L. tropica*-proma.                          34                                                                                            \[[@B22-molecules-22-01071]\]                             
  *L. major*-proma.                            36                                                                                            \[[@B22-molecules-22-01071]\]                             
  Eugenol                                      *L. amazonensis*-proma.     12.65                           red blood cell                    \>65.6                                                    \[[@B23-molecules-22-01071]\]
  *L. infantum chagasi*-proma.                 500                         BALB/c peritoneal macrophages   300                               \[[@B24-molecules-22-01071]\]                             
  *L. infantum chagasi*-axe. ama.              220                                                                                           \[[@B24-molecules-22-01071]\]                             
  *L. infantum chagasi* infected macrophages   100                                                                                           \[[@B24-molecules-22-01071]\]                             
  *L. infantum chagasi*-proma.                 56.13 ± 2.09                                                                                  \[[@B25-molecules-22-01071]\]                             
  *L. infantum chagasi*-ama.                   20.81 ± 1.59                                                                                  \[[@B25-molecules-22-01071]\]                             
  Eugenol (emulsified)                         *L. donovani*-proma.        8.43 ± 0.96                     murine macrophages                \>200                                                     \[[@B26-molecules-22-01071]\]
  *L. donovani*-ama.                           5.05 ± 1.72                                                                                   \[[@B26-molecules-22-01071]\]                             
  Zerumbone                                    *L. donovani*-proma.        2.04                            HL-60                             2.27                                                      \[[@B27-molecules-22-01071],[@B28-molecules-22-01071]\]

ND: not determined; proma.: promastigote; ama.: intracellular amastigote; axe. ama.: axenic amastigote.
